Winton Group’s Adaptive Biotechnologies ADPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-49,700	Closed	-$807K	–	1087
2025 Q4	$807K	Buy	+49,700	New	+$811K	0.03%	532
2023 Q2	–	Sell	-26,383	Closed	-$233K	–	757
2023 Q1	$233K	Buy	26,383 +2,843	+12%	+$25.1K	0.01%	869
2022 Q4	$180K	Buy	23,540 +1,140	+5%	+$8.87K	0.01%	874
2022 Q3	$159K	Sell	22,400 -2,076	-8%	-$19.6K	0.01%	886
2022 Q2	$198K	Buy	24,476 +5,597	+30%	+$49.2K	0.01%	905
2022 Q1	$262K	Buy	18,879 +3,579	+23%	+$56.3K	0.01%	849
2021 Q4	$429K	Buy	15,300 +1,103	+8%	+$33.8K	0.03%	719
2021 Q3	$483K	Sell	14,197 -3,441	-20%	-$124K	0.03%	879
2021 Q2	$721K	Buy	17,638 +634	+4%	+$24.6K	0.04%	707
2021 Q1	$685K	Sell	17,004 -1,524	-8%	-$82.5K	0.04%	698
2020 Q4	$1.1M	Sell	18,528 -14,553	-44%	-$750K	0.08%	355
2020 Q3	$1.61M	Buy	+33,081	New	+$1.39M	0.05%	630